Mycobacterium tuberculosis : Pathogenesis and therapeutic targets
MedComm · 2023-10 · 4 (5)
DOI: 10.1002/mco2.353 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 04.09.2023. Verfasst von Jiaxing Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases and State Key Laboratory of Biotherapy, West China Hospital Sichuan University Chengdu China. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 495 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Tuberculosis (TB) remains a significant public health concern in the 21st century, especially due to drug resistance, coinfection with diseases like immunodeficiency syndrome (AIDS) and coronavirus disease 2019, and the lengthy and costly treatment protocols. In this review, we summarize the pathogenesis of TB infection, therapeutic targets, and corresponding modulators, including first‐line medications, current clinical trial drugs and molecules in preclinical assessment. Understanding the mechanisms of Mycobacterium tuberculosis ( Mtb ) infection and important biological targets can lead to innovative treatments. While most antitubercular agents target pathogen‐related processes, host‐directed therapy (HDT) modalities addressing immune defense, survival mechanisms, and immunopathology also hold promise. Mtb ’s adaptation to the human host involves manipulating host cellular mechanisms, and HDT aims to disrupt this manipulation to enhance treatment effectiveness. Our review provides valuable insights for future anti‐TB drug development efforts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Infectious Diseases and State Key Laboratory of Biotherapy, West China Hospital Sichuan University Chengdu China.
- Department of Thoracic Surgery, West China Hospital Sichuan University Chengdu Sichuan China.
- Lung Cancer Center, West China Hospital Sichuan University Chengdu Sichuan China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, J., Zhang, L., Qiao, W., & Luo, Y. (2023). Mycobacterium tuberculosis : Pathogenesis and therapeutic targets. MedComm, 4(5). https://doi.org/10.1002/mco2.353
Vancouver
Yang J, Zhang L, Qiao W, Luo Y. Mycobacterium tuberculosis : Pathogenesis and therapeutic targets. MedComm. 2023;4(5). doi:10.1002/mco2.353
BibTeX
@article{Yang2023,
author = {Yang, Jiaxing and Zhang, Laiying and Qiao, Wenliang and Luo, Youfu},
title = {Mycobacterium tuberculosis : Pathogenesis and therapeutic targets},
journal = {MedComm},
year = {2023},
volume = {4},
number = {5},
doi = {10.1002/mco2.353}
}
EUVIMED